Castera L - Search Results

1

Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection.

Roulot D, Bourcier V, Grando V, Deny P, Baazia Y, Fontaine H, Bailly F, Castera L, De Ledinghen V, Marcellin P, Poupon R, Bourlière M, Zarski JP, Roudot-Thoraval F; Observational VHC4 Study Group. Roulot D, et al. Among authors: castera l. J Viral Hepat. 2007 Jul;14(7):460-7. doi: 10.1111/j.1365-2893.2006.00823.x. J Viral Hepat. 2007. PMID: 17576387

2

Inhibition of the cyclooxygenase/lipoxygenase pathways to improve interferon alfa efficacy in chronic hepatitis C: a wrong track.

Bastie A, Castera L, Roudot-Thoraval F, Dhumeaux D, Pawlotsky JM. Bastie A, et al. Among authors: castera l. Hepatology. 2000 Feb;31(2):547-8. doi: 10.1002/hep.510310248. Hepatology. 2000. PMID: 10691381 Clinical Trial. No abstract available.

3

[Efficacy and safety of combination therapy with interferon-alpha and ribavirin in patients with chronic hepatitis C coinfected with human immunodeficiency virus].

Castéra L, Roulot D. Castéra L, et al. Gastroenterol Clin Biol. 2000 Oct;24(10):978-9. Gastroenterol Clin Biol. 2000. PMID: 11185920 Free article. French. No abstract available.

4

[Hepatitis C virus-related cirrhosis: is antiviral treatment mandatory?].

Castera L, Roulot D, Trinchet JC, Beaugrand M. Castera L, et al. Gastroenterol Clin Biol. 2001 May;25(5):509-13. Gastroenterol Clin Biol. 2001. PMID: 11521104 Free article. Review. French. No abstract available.

5

[Hepatitis C virus screening in drug users in an addiction out-patient unit].

Grando-Lemaire V, Goisset P, Sorge F, Trinchet JC, Castera L, Roulot D, Sitruk V, Beaugrand M. Grando-Lemaire V, et al. Among authors: castera l. Gastroenterol Clin Biol. 2002 Dec;26(12):1091-6. Gastroenterol Clin Biol. 2002. PMID: 12520196 Free article. French.

6

Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies.

Castéra L, Hézode C, Roudot-Thoraval F, Bastie A, Zafrani ES, Pawlotsky JM, Dhumeaux D. Castéra L, et al. Gut. 2003 Feb;52(2):288-92. doi: 10.1136/gut.52.2.288. Gut. 2003. PMID: 12524415 Free PMC article.

7

[Hepatitis C virus genotype 4: epidemiology and treatment].

Castera L, Morice Y, Grando V, Bon C, Dény P, Roulot D. Castera L, et al. Gastroenterol Clin Biol. 2003 Jun;27(6-7):596-604. Gastroenterol Clin Biol. 2003. PMID: 12910223 Free article. Review. French. No abstract available.

8

Predictive value of early HCV RNA quantitation for sustained response in nonresponders receiving daily interferon and ribavirin therapy.

Trimoulet P, de Lédinghen V, Foucher J, Castéra L, Fleury H, Couzigou P. Trimoulet P, et al. Among authors: castera l. J Med Virol. 2004 Jan;72(1):46-51. doi: 10.1002/jmv.10528. J Med Virol. 2004. PMID: 14635010

9

Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis.

Castéra L, Hézode C, Roudot-Thoraval F, Lonjon I, Zafrani ES, Pawlotsky JM, Dhumeaux D. Castéra L, et al. Gut. 2004 Mar;53(3):420-4. doi: 10.1136/gut.2002.009936. Gut. 2004. PMID: 14960527 Free PMC article.

10

Antiviral action of ribavirin in chronic hepatitis C.

Pawlotsky JM, Dahari H, Neumann AU, Hezode C, Germanidis G, Lonjon I, Castera L, Dhumeaux D. Pawlotsky JM, et al. Among authors: castera l. Gastroenterology. 2004 Mar;126(3):703-14. doi: 10.1053/j.gastro.2003.12.002. Gastroenterology. 2004. PMID: 14988824

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

318 results

Search Page

Filters